|
|
Events for Professionals
For your convenience, major meetings pertinent to thyroid cancer professionals are listed below. Where available, links are provided to further information.
2007 Meetings
April 11-15
American Association of Clinical Endocrinologists (AACE)
Seattle, WA
April 29 - May 1
American Association of Endocrine Surgeons (AAES)
Westin La Paloma Resort
Tucson, Arizona
June 2-4
ASCO
McCormick Place
Chicago, IL
June 2-5
Endocrine Society (ENDO)
Toronto, CA
June 2-6
Society of Nuclear Medicine (SNM)
Washington, DC
September 17-20
American Academy of Otolaryngology – Head and Neck Surgery
AAO-HNSF
Toronto, CA
October 4-7
American Thyroid Association (ATA)
New York, NY
Safety Information
Thyrogen® (thyrotropin alfa for injection) is indicated for use as an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine whole-body scan (WBS) in the follow-up of patients with well-differentiated thyroid cancer. It is a prescription product injected into the muscle. Thyrogen® may not be appropriate for all patients. The most commonly reported adverse events are headache, nausea, weakness and vomiting. Even with a Thyrogen®-stimulated Tg testing and WBS, a risk remains of missing a diagnosis of thyroid cancer or of underestimating the extent of disease. Adverse events should be reported promptly to Genzyme Medical Information at 1-800-745-4447. For more information on Thyrogen®, please see
full prescribing information (PDF), contact the Medical Information department or contact Genzyme
toll free at 1-88-THYROGEN (1-888-497-6436). |
|
 |
|
|
|
Contact Information |
|
|
|
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
888 497 6436
617 768 8050
|
|
|
|
Contact Genzyme |
|
|
|
|
Genzyme Corporate
Terms
and Conditions of Use | Privacy
Policy | This site is intended for United States residents only
© 2003-2008 Genzyme Corporation. All rights reserved.
